外周动脉疾病干预方式对生存的影响:基于VQI数据的倾向性评分匹配分析
本研究利用VQI区域注册数据,对2011年5月至2020年2月期间接受狭窄及闭塞性PAD腔内干预的患者进行倾向性评分匹配,比较POBA、支架置入和斑块旋切术的总生存期。结果显示支架置入较POBA和斑块旋切术显著改善总生存期,而POBA与斑块旋切术间无显著差异,次要结局各组相当。
要点
- 支架置入较POBA和斑块旋切术显著改善PAD患者总生存期。
- POBA与斑块旋切术在总生存期上无显著差异。
- 各组在院内死亡、住院时间、并发症及大截肢率上无统计学差异。
核心结论
- 支架置入在总生存期上显著优于POBA和斑块旋切术,且并发症和截肢率相当。
- POBA与斑块旋切术之间总生存期无显著差异。
研究设计与样本
- 基于VQI区域注册数据的倾向性评分匹配队列研究,纳入2011年5月至2020年2月接受狭窄及闭塞性PAD腔内干预的患者。
- 共识别15281例合格病例,匹配后POBA vs 支架置入、POBA vs 斑块旋切术、支架 vs 斑块旋切术分别纳入6094、4032和3312例。
- 采用逆概率治疗加权法比较院内死亡、住院时间、并发症和大截肢等次要结局。
主要发现
- 支架置入较POBA显著改善总生存期(P < 0.001)。
- 支架置入较斑块旋切术显著改善总生存期(P < 0.001)。
- 多变量Cox比例风险模型显示,支架置入较POBA死亡风险降低30%(HR: 0.7; 95% CI: 0.6-0.82; P < 0.001)。
- 支架置入较斑块旋切术死亡风险降低40%(HR: 0.6; 95% CI: 0.48-0.75; P < 0.001)。
- POBA与斑块旋切术间无显著差异,其他次要结局各组间无统计学差异。
临床怎么用
- 在PAD腔内干预选择中,支架置入可能较POBA和斑块旋切术带来生存获益。
- 对于间歇性跛行患者,需注意其年死亡风险极低,应审慎评估干预方式对死亡率的影响。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atherectomy is currently being used extensively for occlusive peripheral artery disease (PAD) interventions without proven benefits. This analysis examines the effects of atherectomy and other endovascular interventions on patient survival. OBJECTIVES: The aim of this study is to compare overall survival for patients undergoing PAD endovascular interventions, such as plain old balloon angioplasty (POBA), stent deployment and atherectomy. METHODS: Propensity score matched cohorts were constructed to conduct pairwise comparisons of overall survival in patients who underwent stenosis and occlusive PAD interventions between May 2011 and February 2020 using Vascular Quality Initiative (VQI) regional registry data. Inverse probability treatment weighting method was used to compare secondary outcomes of in-hospital mortality, length of stay, complications and major amputations. Comparative analysis was performed for POBA vs stenting, POBA vs atherectomy, and stenting vs atherectomy. RESULTS: A total number of 15281 eligible cases were identified. After propensity score matching, 6094, 4032, and 3312 cases were used to compare POBA versus stent deployment, POBA versus atherectomy and stent versus atherectomy, respectively. Stent deployment had significantly better overall survival compared with POBA and atherectomy (P < 0.001). Multivariable Cox proportional hazard models suggested stenting was associated with a reduction in mortality hazard by 30% compared with POBA (HR: 0.7; 95% CI: 0.6-0.82; P < 0.001) and a 40% mortality reduction compared with atherectomy (HR: 0.6; 95% CI: 0.48-0.75; P < 0.001). No significant difference was found between POBA and atherectomy. There was no statistical difference in other secondary outcomes which were comparable among all cohorts. CONCLUSIONS: Stent deployment was significantly superior to POBA and atherectomy in terms of overall survival with comparable complication and amputation rates. The natural history of PAD patients presenting with claudication is associated with an extremely low annual mortality risk. Therefore, further examinations of outcomes, especially in regards to mortality rates, both POBA and atherectomy on the management of PAD patients especially those presenting with claudication is warranted.
引用
- Mukherjee D, Liu C, Jadali A, et al. Effects of Peripheral Arterial Disease Interventions on Survival: A Propensity-Score Matched Analysis Using VQI Data. Ann Vasc Surg. 2021. PMID: 34644639. doi:10.1016/j.avsg.2021.08.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。